Prestige Consumer Healthcare Inc
PBH
Get informed when a big investor buys or sells
+ FollowEarnings Call Q2 2023
November 6, 2022 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
169.2% upsideUndervalued by 169.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.25 Billion |
|---|---|
| Enterprise Value | $2.24 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $3.93 |
| Beta | 0.4 |
| Outstanding Shares | 47,433,000 |
Return
| Return on Equity | 10.08% |
|---|---|
| Return on Assets | 5.45% |
| Return on Invested Capital | 8.87% |
Valuation & Multiples
| P/E Ratio | 11.85 |
|---|---|
| PEG | 156.28 |
| Price to Sales | 2.07 |
| Price to Book Ratio | 1.17 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | 7.48 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 108.53%▲ 3.23% |
|---|---|
| Total Invested | $3.08B▼ 3.40% |
| Investors Holding | 351▼ 1.00% |
ESG Score
No data
About Prestige Consumer Healthcare Inc
Relevant Senate Committees
This committee's technical analysis and revenue estimates are crucial to tax legislation, directly influencing corporate tax structures, R&D incentives, and the overall financial burden on manufacturing companies like PBH.
This committee's control over taxation (corporate tax rates, R&D credits) and trade policy directly impacts the profitability, international supply chains, and overall valuation of a manufacturing company like PBH.
This committee's direct oversight of the FDA (drug approval, manufacturing standards, labeling) and labor laws are fundamentally critical to the operations, product pipeline, and cost structure of a pharmaceutical preparation manufacturer.
This committee's oversight of intellectual property (patents, trademarks for brands) and antitrust laws (for potential M&A) are highly relevant to a company manufacturing branded pharmaceutical preparations.
The committee's jurisdiction over interstate commerce and the FTC directly impacts advertising, marketing, and fair competition regulations crucial for consumer product companies like PBH.